These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 16847431)
21. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Proost P; Mortier A; Loos T; Vandercappellen J; Gouwy M; Ronsse I; Schutyser E; Put W; Parmentier M; Struyf S; Van Damme J Blood; 2007 Jul; 110(1):37-44. PubMed ID: 17363734 [TBL] [Abstract][Full Text] [Related]
22. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Ruschpler P; Lorenz P; Eichler W; Koczan D; Hänel C; Scholz R; Melzer C; Thiesen HJ; Stiehl P Arthritis Res Ther; 2003; 5(5):R241-52. PubMed ID: 12932287 [TBL] [Abstract][Full Text] [Related]
23. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Xanthou G; Duchesnes CE; Williams TJ; Pease JE Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299 [TBL] [Abstract][Full Text] [Related]
24. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. Singh UP; Singh R; Singh S; Karls RK; Quinn FD; Taub DD; Lillard JW BMC Immunol; 2008 Jun; 9():25. PubMed ID: 18533024 [TBL] [Abstract][Full Text] [Related]
25. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis. Shin JJ; Glickstein LJ; Steere AC Arthritis Rheum; 2007 Apr; 56(4):1325-35. PubMed ID: 17393419 [TBL] [Abstract][Full Text] [Related]
26. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. Soejima K; Rollins BJ J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110 [TBL] [Abstract][Full Text] [Related]
28. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412 [TBL] [Abstract][Full Text] [Related]
29. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Brentano F; Schorr O; Gay RE; Gay S; Kyburz D Arthritis Rheum; 2005 Sep; 52(9):2656-65. PubMed ID: 16142732 [TBL] [Abstract][Full Text] [Related]
30. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952 [TBL] [Abstract][Full Text] [Related]
31. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands. McColl SR; Mahalingam S; Staykova M; Tylaska LA; Fisher KE; Strick CA; Gladue RP; Neote KS; Willenborg DO Lab Invest; 2004 Nov; 84(11):1418-29. PubMed ID: 15322564 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. Feferman T; Maiti PK; Berrih-Aknin S; Bismuth J; Bidault J; Fuchs S; Souroujon MC J Immunol; 2005 May; 174(9):5324-31. PubMed ID: 15843529 [TBL] [Abstract][Full Text] [Related]
33. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716 [TBL] [Abstract][Full Text] [Related]
34. Induction of metalloproteinases expression by TLR ligands in human fibroblast like synoviocytes from juvenile idiopathic arthritis patients. Agarwal S; Misra R; Aggarwal A Indian J Med Res; 2010 Jun; 131():771-9. PubMed ID: 20571165 [TBL] [Abstract][Full Text] [Related]
35. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. Christensen JE; de Lemos C; Moos T; Christensen JP; Thomsen AR J Immunol; 2006 Apr; 176(7):4235-43. PubMed ID: 16547260 [TBL] [Abstract][Full Text] [Related]
36. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. Hildebrandt GC; Corrion LA; Olkiewicz KM; Lu B; Lowler K; Duffner UA; Moore BB; Kuziel WA; Liu C; Cooke KR J Immunol; 2004 Aug; 173(3):2050-9. PubMed ID: 15265940 [TBL] [Abstract][Full Text] [Related]
37. Optic neuritis: chemokine receptor CXCR3 and its ligands. Sørensen TL; Roed H; Sellebjerg F Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705 [TBL] [Abstract][Full Text] [Related]
38. Differential regulation by IFN‑γ on TNF‑α‑induced chemokine expression in synovial fibroblasts from temporomandibular joint. Ohta K; Naruse T; Kato H; Ishida Y; Nakagawa T; Ono S; Shigeishi H; Takechi M Mol Med Rep; 2017 Nov; 16(5):6850-6857. PubMed ID: 28901435 [TBL] [Abstract][Full Text] [Related]
39. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. Means TK; Hayashi F; Smith KD; Aderem A; Luster AD J Immunol; 2003 May; 170(10):5165-75. PubMed ID: 12734364 [TBL] [Abstract][Full Text] [Related]
40. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Balashov KE; Rottman JB; Weiner HL; Hancock WW Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]